Molecule Triggers Fat in Liver
Research has proven that saturated fats and trans fattyacids cause high levels of cholesterol and triglycerides. Bothare risk factors in cardiovascular disease and some types ofcancer. A new study identified a molecule in the liver thatexplains how eating fatty foods increases the risk of heartdisease and cancer.
The researchers reported that the harmful effects of saturatedand trans fats are activated by PGC-1beta, a biochemicalswitch located in the liver cells. The investigatorsexplained that, when PGC-1beta is set in motion by harmfulfats, it alters liver metabolism and causes an upsurge of theliver's production of very low-density lipoprotein (VLDL). Inturn, the VLDL produces low-density lipoprotein. Furthermore,it manufactures higher levels of triglycerides.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025